Caprazamycins, Novel Lipo-nucleoside Antibiotics, from Streptomyces sp.

  • Igarashi M
  • Takahashi Y
  • Shitara T
  • et al.
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Novel antibiotics, active against acid-fast bacteria, caprazamycins, were isolated from the culture broth of Streptomyces sp. MK730-62F2. The planar structures of the compounds were determined by 2D NMR spectroscopic study. Furthermore, the absolute structure of caprazamycin B (2) was established by NMR spectroscopy and X-ray crystallography of its degradation products and by total synthesis of the 5-amino-5-deoxy-D-ribose moiety. In the course of degradation studies of 2 under alkaline and acidic conditions, we obtained the two core components, caprazene (11) and caprazol (14), respectively, in high yield. Structurally, caprazamycins belong to a family of lipo-uridyl antibiotics, which have been discovered as specific inhibitors of a bacterial translocase.

Cite

CITATION STYLE

APA

Igarashi, M., Takahashi, Y., Shitara, T., Nakamura, H., Naganawa, H., Miyake, T., & Akamatsu, Y. (2005). Caprazamycins, Novel Lipo-nucleoside Antibiotics, from Streptomyces sp. The Journal of Antibiotics, 58(5), 327–337. https://doi.org/10.1038/ja.2005.41

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free